During the past decade, SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg) conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)" are "Healthy" (4 trials) and "Hepatitis B" (1 trials). Many other conditions were trialed in "SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)" in a lesser frequency.

Most popular intervention types in "SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Cobicistat" (1 trials), "Darunavir" (1 trials), "Darunavir/Cobicistat FDC" (1 trials) and "Etravirine" (1 trials). Other intervention names were less common.

The vast majority of trials in "SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)" are 5 trials for "All" genders.

Currently, there are NaN active trials in "SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg), 4 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".